SQUEEZE
Maximizing the effect of prescription drugs in rheumatoid arthritis
Project Manager
ABOUT THE PROJECT
SQUEEZE is a European consortium that has been awarded funding from Horizon Europe, the EU's research program to research the treatment of arthritis (rheumatoid arthritis). There will be several parts of the project that deal with different approaches to arthritis treatment. REMEDY has the main responsibility for the part of the project that works with therapeutic drug monitoring. This includes a large randomized controlled trial, RA-DRUM.
More information about the entire SQUEEZE can be found on the consortium website:
WHO CAN JOIN?
Patients over the age of 18 diagnosed with rheumatoid arthritis (arthritis). Recruitment of participants has not yet begun.
WHAT DOES THE STUDY INCLUDE?
More information about the study is forthcoming.
This project has received funding from the European Union's Horizon Europe research and innovation program under grant agreement no. 101095052. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Unior nor the granting authority can be held responsible for them.